Trial Profile
Asian Multicentre, Double Blind, Randomised, Placebo Controlled Pilot Study, to Assess the Impact of Dysport® Intramuscular Injections When Administered Within the First 12 Weeks After Stroke on the Time to Spasticity Progression in Adult Subjects With Upper Limb (UL) Spasticity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms ONTIME Pilot
- Sponsors Ipsen
- 04 Jul 2018 According to a an Ipsen media release, data from the study will be presented at 12th International Society of Physical and Rehabilitation Medicine World Congress.
- 07 Feb 2018 According to an Ipsen media release, data will be presented at the World Congress for Neurorehabilitation (WCNR 2018).
- 08 Jun 2017 Results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders